Trace Neuroscience Launches with $101M to Target ALS and Neurodegenerative Diseases
Key Highlights $101M Series A funding led by Third Rock Ventures and others, supporting ALS and neurodegenerative therapies. UNC13A-focused…
Browsing Tag
Eric Green
2 posts
Seaport Therapeutics Expands Executive Team with Key Appointments
Key Highlights Antony Loebel, M.D., appointed as Chief Medical Officer and President of Clinical Development. Lana Gladstein, J.D.,…